BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2021
View Archived Issues
Onegene Biotechnology presents OGB-21502, a novel antifibrotic agent
Read More
Preclinical assessment of the novel GLP-1 receptor agonist GZR-18
Read More
DYNE-101 shows efficacy in mouse model of myotonic dystrophy type 1
Read More
Researchers patent new glucose triptolide conjugates
Read More
ViiV Healthcare discloses new anti-HIV compounds
Read More
New 5-HT2 receptor agonists identified
Read More
SARS-CoV-2 virus-specific T-cell therapy may be effective against variants
Read More
Suzhou Kintor Pharmaceuticals discloses new PROTACs
Read More
VRDN-001 potently inhibits IGF-1R signaling in vitro
Read More
TYK Medicines discovers new EGFR and/or HER2 mutant inhibitors
Read More
Targeting Th17 and cdT17 function protects against ICI-induced autoimmune thyroiditis
Read More
[18F]-TFB radiotracer useful for PET imaging of glioblastoma
Read More
Discovery of novel thiazolidinedione derivatives that inhibit HBV internalization
Read More
89Zr immune PET/CT improves response assessment in murine model of lung cancer under immunotherapy
Read More
Reduced Shh signaling is involved in the formation and expression of levodopa-induced dyskinesia
Read More
A global structural and competitive landscape of key antibody binding sites on SARS-CoV-2 spike
Read More
Q-State announces ASO discovery programs targeting neurodegenerative disorders
Read More
Sweet taste of success for asymmetric organocatalysis
Read More